TY - JOUR
T1 - The role of placebo effects in immune-related conditions
T2 - mechanisms and clinical considerations
AU - Smits, Rosanne M.
AU - Veldhuijzen, Dieuwke S.
AU - Wulffraat, Nico M.
AU - Evers, Andrea W.M.
N1 - Funding Information:
This work was supported by grants of the Dutch Arthritis Society (ReumaNederland) (16-3-401); the European Research Council (ERC Consolidator Grant ERC-2013-CoG-617700), and the Dutch Organisation for Scientific Research (NWO-Vici grant 01 6.V I CL770. L52).
Publisher Copyright:
© 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2018/9/2
Y1 - 2018/9/2
N2 - Introduction: Placebo effects are powerful modulators in clinical outcomes and can either result in treatment benefits or harms, known as placebo and nocebo effects. To harness these outcomes, it is important to focus on the underlying processes that steer these effects, namely by learning through expectations and conditioning. In this review, we focus on the influence of placebo effects on subjective and physiological levels of immune-related conditions (e.g. lymphocyte proliferation, cytokine production or other inflammatory markers). Areas covered: A literature search is conducted in the databases PubMed and PsychInfo by making use of keywords such as ‘expectations’, ‘classical conditioning’, ‘cytokines’, ‘immune system’, ‘learned immunosuppression’, and covers studies done in animals, experimental studies in healthy controls as well as studies performed in immune-related patient populations. Expert commentary: We report on the presence of placebo effects in RCTs in immune-related conditions and review findings that demonstrate the ability to learn immune responses in both experimental animal and human placebo studies making use of conditioning paradigms with immunomodulating drug agents. We also discuss results to utilize placebo effects by means of classical conditioning principles in medication regimens for patient populations and elaborate on promising findings of preliminary studies focusing on this topic.
AB - Introduction: Placebo effects are powerful modulators in clinical outcomes and can either result in treatment benefits or harms, known as placebo and nocebo effects. To harness these outcomes, it is important to focus on the underlying processes that steer these effects, namely by learning through expectations and conditioning. In this review, we focus on the influence of placebo effects on subjective and physiological levels of immune-related conditions (e.g. lymphocyte proliferation, cytokine production or other inflammatory markers). Areas covered: A literature search is conducted in the databases PubMed and PsychInfo by making use of keywords such as ‘expectations’, ‘classical conditioning’, ‘cytokines’, ‘immune system’, ‘learned immunosuppression’, and covers studies done in animals, experimental studies in healthy controls as well as studies performed in immune-related patient populations. Expert commentary: We report on the presence of placebo effects in RCTs in immune-related conditions and review findings that demonstrate the ability to learn immune responses in both experimental animal and human placebo studies making use of conditioning paradigms with immunomodulating drug agents. We also discuss results to utilize placebo effects by means of classical conditioning principles in medication regimens for patient populations and elaborate on promising findings of preliminary studies focusing on this topic.
KW - Classical conditioning
KW - cytokines
KW - immune system
KW - inflammation
KW - learned immunosuppression
KW - nocebo effects
KW - placebo effects
UR - http://www.scopus.com/inward/record.url?scp=85053822917&partnerID=8YFLogxK
U2 - 10.1080/1744666X.2018.1516144
DO - 10.1080/1744666X.2018.1516144
M3 - Review article
AN - SCOPUS:85053822917
SN - 1744-666X
VL - 14
SP - 761
EP - 770
JO - Expert Review of Clinical Immunology
JF - Expert Review of Clinical Immunology
IS - 9
ER -